Homebiotech

biotech

biotech

Base to Base biotech podcast 57: Keeping drugs cool, and treatment resistant depression

Jim Cornall - May 1, 2026

biotech

ELREXFIO improves progression-free survival for patients with relapsed or refractory multiple myeloma

Jim Cornall - April 30, 2026

biotech

Aragen launches India’s first women-led chemistry synthesis laboratory

Jim Cornall - April 30, 2026

biotech

Vaccine strategy induces broadly neutralising HIV antibodies

Jim Cornall - April 30, 2026

biotech

HotSpot Therapeutics presents preclinical small molecule data

Jim Cornall - July 9, 2025

biotech

BerGenBio and Oncoinvent announce proposed merger

Jim Cornall - July 9, 2025

biotech

InnoCare announces solid tumour trial in China

Jim Cornall - July 9, 2025

biotech

PhaseV debuts new ClinOps AI platform

Jim Cornall - July 9, 2025

biotech

Positive phase 3 results for Amgen gastric cancer drug

Jim Cornall - July 8, 2025

biotech

Synfini adds $8.9m discovery funding to speed small molecule drug development

Jim Cornall - July 8, 2025

biotech

Breakthrough in overcoming cancer drug resistance

Jim Cornall - July 8, 2025

biotech

Molecules fight HIV and other viral infections

Jim Cornall - July 8, 2025

1...636465...73 Page 64 of 73

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Base to Base biotech podcast 57: Keeping drugs cool, and treatment resistant depression

Jim Cornall - May 1, 2026 0

This week, our conversations are with Uwe Diegel, CEO of Lifeina, about their cooling technologies, and with Dirk Beher, CEO of FundaMental Pharma, about...

ELREXFIO improves progression-free survival for patients with relapsed or refractory multiple myeloma

biotech Jim Cornall - April 30, 2026 0

Aragen launches India’s first women-led chemistry synthesis laboratory

biotech Jim Cornall - April 30, 2026 0

Vaccine strategy induces broadly neutralising HIV antibodies

biotech Jim Cornall - April 30, 2026 0

New target for cancer treatment

biotech Jim Cornall - April 29, 2026 0